Specialty market
China Ophthalmology Market Outlook 2026
China's ophthalmology market reached USD 22.3 billion in 2025 with an 11.8% CAGR through 2030, propelled by myopia epidemic, refractive surgery volume (SMILE/LASIK/ICL), and rising adult cataract and retina volumes.
Market size (2025)
USD 22.3 billion
CAGR
11.8%
Forecast (2030)
USD 38.8 billion
Geography
Mainland China ophthalmology — refractive, cataract, retina, glaucoma, pediatric
International-patient cost band
$1,100–$5,200 USD
Market size, 2021–2030
Mainland China ophthalmology — refractive, cataract, retina, glaucoma, pediatric.
| Year | Market size (USD) | Status |
|---|---|---|
| 2021 | USD 12.8 billion | Historical |
| 2022 | USD 14.7 billion | Historical |
| 2023 | USD 16.9 billion | Historical |
| 2024 | USD 19.4 billion | Historical |
| 2025 | USD 22.3 billion | Latest actual |
| 2026 | USD 24.9 billion | Forecast |
| 2030 | USD 38.8 billion | Forecast |
Demand drivers
- Myopia prevalence in Chinese teens >70% — among the highest globally; drives SMILE/LASIK/ICL volume.
- Aging cataract demand: ~110 million Chinese aged 60+ with cataract diagnosis.
- Refractive surgery price competition: Aier Eye Hospital chain drove per-eye SMILE pricing from RMB 23,000 to RMB 14,500 since 2020.
- Inbound from US/UK expat communities for SMILE (cheaper and faster pathway than home).
Supply-side landscape
- Class A flagship: Zhongshan Ophthalmic Centre (Sun Yat-sen University) — China's #1 eye hospital.
- Listed eye chains: Aier Eye Hospital (largest), He Eye Hospital, Bright Eye Hospital, Tianjin Eye Hospital network.
- Premium private: Beijing Tongren (also Class A), Shanghai Eye & ENT (Class A), Optical Valley (multiple cities).
- International-patient cost: SMILE USD 1,400–2,400 per eye, LASIK USD 1,100–1,900, ICL USD 3,200–5,200.
Risks & headwinds
- Operator dispersion: outcome variability higher in low-volume centres.
- Post-LASIK dry eye and night-vision complaints remain quality flags — premium centres use sapphire-blade femto and excimer with eye-tracker.
- Rapid technology cycling (Carl Zeiss VisuMax 800, Schwind SmartSight) means platform vintage matters.
Notable providers
Class A
Zhongshan Ophthalmic Centre
China's #1 eye hospital — cataract, refractive, retina subspecialty.
Provider
Class AAier Eye Hospital Group (SH:300015)
Largest listed eye chain in China — ~700 centres globally.
Beijing Tongren Hospital Ophthalmology
Class A teaching hospital with complex retina and glaucoma.
Class AShanghai Eye & ENT
Fudan-affiliated specialised eye hospital.
Frequently asked
- How big is the China ophthalmology market in 2026?
- USD 22.3 billion in 2025, forecast to USD 38.8 billion by 2030 (11.8% CAGR). Myopia-driven refractive surgery and aging-driven cataract are the two largest sub-segments.
- How much does SMILE cost in China for international patients?
- USD 1,400–2,400 per eye all-in at a Class A international department, vs USD 4,500–6,800 per eye in US private settings. SMILE recovery is faster than LASIK with a fly-home window of 3–5 days.
- Which Chinese eye hospitals are best for international patients?
- Zhongshan Ophthalmic Centre (Guangzhou), Beijing Tongren Hospital, Shanghai Eye & ENT, and selected Aier Eye Hospital flagship centres in Beijing, Shanghai and Shenzhen.
Sources
- Aier Eye Hospital Group FY2024 annual report (SH:300015)
- Chinese Ophthalmological Society 2024 surgical volume report
- Frost & Sullivan China Ophthalmology Market Outlook 2026
- Partner-network 2026 international-patient ophthalmology quote data
Last reviewed: 2026-05-12.
Going beyond the report
For a written quote from two Class A international departments — covering procedure, hospital match, recovery and visa — start the quote wizard.